PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹627 Cr | ₹570 Cr | ₹547 Cr | ₹657 Cr | ₹853 Cr |
What is the latest Total Current Liabilities ratio of PFIZER ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹627 Cr |
| Mar2025 | ₹570 Cr |
| Mar2024 | ₹547 Cr |
| Mar2023 | ₹657 Cr |
| Mar2022 | ₹853 Cr |
How is Total Current Liabilities of PFIZER Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹627 Cr | 10.18 | |
| Mar2025 | ₹570 Cr | 4.20 | |
| Mar2024 | ₹547 Cr | -16.85 | |
| Mar2023 | ₹657 Cr | -22.93 | |
| Mar2022 | ₹853 Cr | - | |
Compare Total Current Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,253.2 Cr | 1.8% | 3.4% | -13.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 1.8% |
3.4% |
-13.3% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses